Dureza, Clera Rose M.

HRN: 15-78-11  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2026
CEFUROXIME 1.5GM (VIAL)
08/07/2026
08/07/2026
IV
1.5gm
Prior To Induction
GI TB Resolved; For OR
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Prophylaxis    Compliance to guidelines: